Olga Radkevich-Brown, Ph.D.
Affiliations: | 2007 | Cancer Biology | Wayne State University, Detroit, MI, United States |
Area:
Oncology, ImmunologyGoogle:
"Olga Radkevich-Brown"Parents
Sign in to add mentorWei-Zen Wei | grad student | 2007 | Wayne State | |
(Her-2 DNA vaccination and intratumoral immune modulation.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Yang X, Zhang X, Mortenson ED, et al. (2013) Cetuximab-mediated tumor regression depends on innate and adaptive immune responses. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 91-100 |
Park S, Jiang Z, Mortenson ED, et al. (2010) The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity. Cancer Cell. 18: 160-70 |
Jacob JB, Quaglino E, Radkevich-Brown O, et al. (2010) Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity. Cancer Research. 70: 119-28 |
Radkevich-Brown O, Piechocki MP, Back JB, et al. (2010) Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression. Cancer Immunology, Immunotherapy : Cii. 59: 409-17 |
Jacob JB, Quaglino E, Radkevich-Brown O, et al. (2010) Correction: Combining human and rat sequences in Her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity (Cancer Research (2010) 70, (119-128)) Cancer Research. 70: 2569 |
Radkevich-Brown O, Jacob J, Kershaw M, et al. (2009) Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice. Cancer Research. 69: 212-8 |
Whittington PJ, Radkevich-Brown O, Jacob JB, et al. (2009) Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity. Cancer Immunology, Immunotherapy : Cii. 58: 759-67 |
Wei WZ, Jacob J, Radkevich-Brown O, et al. (2008) The "A, B and C" of Her-2 DNA vaccine development. Cancer Immunology, Immunotherapy : Cii. 57: 1711-7 |